Skip to main content
logo
Kiora Pharmaceuticals, Inc. (KPRX)
NASDAQ: KPRX · Real-Time Price · USD
2.660
+0.040 (1.53%)
At close: Aug 21, 2026, 4:00 PM EDT
2.680
+0.020 (0.75%)
After-hours: Aug 21, 2026, 6:59 PM EDT

Kiora Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
--16.02---
Revenue Growth
------
Gross Profit
-3.88-3.7111.12-4.03-3.45-5.35
Operating Income
-9.77-9.465.58-8.69-10.73-10.57
Net Income
-10.99-10.843.59-13.04-13.58-13.77
Earnings Per Share
-2.30-2.640.87-24.25-166.94-514.04
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
16.8417.0926.792.455.967.85
Total Debt
0.330.370.060.110.110.21
Net Cash (Debt)
16.5116.7226.732.355.867.65
Net Cash Growth
-18.43%-37.46%1038.72%-59.93%-23.37%1150.70%
Net Cash Per Share
3.454.016.484.3672.00285.39

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-8.51-9.968.56-9.56-10.43-10.68
Capital Expenditures
-0.11-0.11-0.01---0.06
Free Cash Flow
-8.61-10.078.55-9.56-10.43-10.74
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
--69.43%---
Operating Margin
--34.84%---
Pretax Margin
--35.33%---
Profit Margin
--22.44%---
FCF Margin
--53.39%---

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--2.76---
P/FCF Ratio
--1.16---
PS Ratio
--0.62---